Published Nov 7, 2026, 9:50 AM ET · Updated 6 days ago · 3 sources
Novartis Abandons Heart Drug After Surprising Failure in Key Study
bloomberg
·
Original Report
INFERY
Novartis AG is largely abandoning an experimental drug analysts once considered a potential blockbuster after a study found it had little promise for preventing heart attacks and cardiovascular deaths.